0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostaglandin Analogs Market Research Report 2025
Published Date: 2025-07-07
|
Report Code: QYRE-Auto-9A10175
Home | Market Reports
Global Prostaglandin Analogs Market Insights Forecast to 2028
BUY CHAPTERS

Global Prostaglandin Analogs Market Research Report 2025

Code: QYRE-Auto-9A10175
Report
2025-07-07
Pages:61
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Prostaglandin Analogs Market

The global market for Prostaglandin Analogs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Prostaglandin analogues are a class of drugs that bind to a prostaglandin receptor,it used to treat hypotrichosis of the eyelashes and intraocular pressure in open angle glaucoma or ocular hypertension.
North American market for Prostaglandin Analogs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prostaglandin Analogs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Prostaglandin Analogs in Clinic is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Prostaglandin Analogs include Pfizer, Novartis, Merck, Allergan, Newchem S.p.A., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostaglandin Analogs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin Analogs.
The Prostaglandin Analogs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostaglandin Analogs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostaglandin Analogs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Prostaglandin Analogs Market Report

Report Metric Details
Report Name Prostaglandin Analogs Market
Segment by Type
  • Xalatan
  • Travatan
  • Lumigan
  • Tafluprost
Segment by Application
  • Clinic
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Novartis, Merck, Allergan, Newchem S.p.A.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Prostaglandin Analogs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prostaglandin Analogs Market report?

Ans: The main players in the Prostaglandin Analogs Market are Pfizer, Novartis, Merck, Allergan, Newchem S.p.A.

What are the Application segmentation covered in the Prostaglandin Analogs Market report?

Ans: The Applications covered in the Prostaglandin Analogs Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Prostaglandin Analogs Market report?

Ans: The Types covered in the Prostaglandin Analogs Market report are Xalatan, Travatan, Lumigan, Tafluprost

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostaglandin Analogs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Xalatan
1.2.3 Travatan
1.2.4 Lumigan
1.2.5 Tafluprost
1.3 Market by Application
1.3.1 Global Prostaglandin Analogs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostaglandin Analogs Market Perspective (2020-2031)
2.2 Global Prostaglandin Analogs Growth Trends by Region
2.2.1 Global Prostaglandin Analogs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Prostaglandin Analogs Historic Market Size by Region (2020-2025)
2.2.3 Prostaglandin Analogs Forecasted Market Size by Region (2026-2031)
2.3 Prostaglandin Analogs Market Dynamics
2.3.1 Prostaglandin Analogs Industry Trends
2.3.2 Prostaglandin Analogs Market Drivers
2.3.3 Prostaglandin Analogs Market Challenges
2.3.4 Prostaglandin Analogs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostaglandin Analogs Players by Revenue
3.1.1 Global Top Prostaglandin Analogs Players by Revenue (2020-2025)
3.1.2 Global Prostaglandin Analogs Revenue Market Share by Players (2020-2025)
3.2 Global Prostaglandin Analogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Prostaglandin Analogs Revenue
3.4 Global Prostaglandin Analogs Market Concentration Ratio
3.4.1 Global Prostaglandin Analogs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostaglandin Analogs Revenue in 2024
3.5 Global Key Players of Prostaglandin Analogs Head office and Area Served
3.6 Global Key Players of Prostaglandin Analogs, Product and Application
3.7 Global Key Players of Prostaglandin Analogs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostaglandin Analogs Breakdown Data by Type
4.1 Global Prostaglandin Analogs Historic Market Size by Type (2020-2025)
4.2 Global Prostaglandin Analogs Forecasted Market Size by Type (2026-2031)
5 Prostaglandin Analogs Breakdown Data by Application
5.1 Global Prostaglandin Analogs Historic Market Size by Application (2020-2025)
5.2 Global Prostaglandin Analogs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Prostaglandin Analogs Market Size (2020-2031)
6.2 North America Prostaglandin Analogs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Prostaglandin Analogs Market Size by Country (2020-2025)
6.4 North America Prostaglandin Analogs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostaglandin Analogs Market Size (2020-2031)
7.2 Europe Prostaglandin Analogs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Prostaglandin Analogs Market Size by Country (2020-2025)
7.4 Europe Prostaglandin Analogs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostaglandin Analogs Market Size (2020-2031)
8.2 Asia-Pacific Prostaglandin Analogs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Prostaglandin Analogs Market Size by Region (2020-2025)
8.4 Asia-Pacific Prostaglandin Analogs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostaglandin Analogs Market Size (2020-2031)
9.2 Latin America Prostaglandin Analogs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Prostaglandin Analogs Market Size by Country (2020-2025)
9.4 Latin America Prostaglandin Analogs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostaglandin Analogs Market Size (2020-2031)
10.2 Middle East & Africa Prostaglandin Analogs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Prostaglandin Analogs Market Size by Country (2020-2025)
10.4 Middle East & Africa Prostaglandin Analogs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prostaglandin Analogs Introduction
11.1.4 Pfizer Revenue in Prostaglandin Analogs Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Prostaglandin Analogs Introduction
11.2.4 Novartis Revenue in Prostaglandin Analogs Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Prostaglandin Analogs Introduction
11.3.4 Merck Revenue in Prostaglandin Analogs Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Prostaglandin Analogs Introduction
11.4.4 Allergan Revenue in Prostaglandin Analogs Business (2020-2025)
11.4.5 Allergan Recent Development
11.5 Newchem S.p.A.
11.5.1 Newchem S.p.A. Company Details
11.5.2 Newchem S.p.A. Business Overview
11.5.3 Newchem S.p.A. Prostaglandin Analogs Introduction
11.5.4 Newchem S.p.A. Revenue in Prostaglandin Analogs Business (2020-2025)
11.5.5 Newchem S.p.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Prostaglandin Analogs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Xalatan
 Table 3. Key Players of Travatan
 Table 4. Key Players of Lumigan
 Table 5. Key Players of Tafluprost
 Table 6. Global Prostaglandin Analogs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Prostaglandin Analogs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Prostaglandin Analogs Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Prostaglandin Analogs Market Share by Region (2020-2025)
 Table 10. Global Prostaglandin Analogs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Prostaglandin Analogs Market Share by Region (2026-2031)
 Table 12. Prostaglandin Analogs Market Trends
 Table 13. Prostaglandin Analogs Market Drivers
 Table 14. Prostaglandin Analogs Market Challenges
 Table 15. Prostaglandin Analogs Market Restraints
 Table 16. Global Prostaglandin Analogs Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Prostaglandin Analogs Market Share by Players (2020-2025)
 Table 18. Global Top Prostaglandin Analogs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostaglandin Analogs as of 2024)
 Table 19. Ranking of Global Top Prostaglandin Analogs Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Prostaglandin Analogs Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Prostaglandin Analogs, Headquarters and Area Served
 Table 22. Global Key Players of Prostaglandin Analogs, Product and Application
 Table 23. Global Key Players of Prostaglandin Analogs, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Prostaglandin Analogs Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Prostaglandin Analogs Revenue Market Share by Type (2020-2025)
 Table 27. Global Prostaglandin Analogs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Prostaglandin Analogs Revenue Market Share by Type (2026-2031)
 Table 29. Global Prostaglandin Analogs Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Prostaglandin Analogs Revenue Market Share by Application (2020-2025)
 Table 31. Global Prostaglandin Analogs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Prostaglandin Analogs Revenue Market Share by Application (2026-2031)
 Table 33. North America Prostaglandin Analogs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Prostaglandin Analogs Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Prostaglandin Analogs Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Prostaglandin Analogs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Prostaglandin Analogs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Prostaglandin Analogs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Prostaglandin Analogs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Prostaglandin Analogs Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Prostaglandin Analogs Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Prostaglandin Analogs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Prostaglandin Analogs Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prostaglandin Analogs Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Prostaglandin Analogs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Prostaglandin Analogs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Prostaglandin Analogs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Pfizer Company Details
 Table 49. Pfizer Business Overview
 Table 50. Pfizer Prostaglandin Analogs Product
 Table 51. Pfizer Revenue in Prostaglandin Analogs Business (2020-2025) & (US$ Million)
 Table 52. Pfizer Recent Development
 Table 53. Novartis Company Details
 Table 54. Novartis Business Overview
 Table 55. Novartis Prostaglandin Analogs Product
 Table 56. Novartis Revenue in Prostaglandin Analogs Business (2020-2025) & (US$ Million)
 Table 57. Novartis Recent Development
 Table 58. Merck Company Details
 Table 59. Merck Business Overview
 Table 60. Merck Prostaglandin Analogs Product
 Table 61. Merck Revenue in Prostaglandin Analogs Business (2020-2025) & (US$ Million)
 Table 62. Merck Recent Development
 Table 63. Allergan Company Details
 Table 64. Allergan Business Overview
 Table 65. Allergan Prostaglandin Analogs Product
 Table 66. Allergan Revenue in Prostaglandin Analogs Business (2020-2025) & (US$ Million)
 Table 67. Allergan Recent Development
 Table 68. Newchem S.p.A. Company Details
 Table 69. Newchem S.p.A. Business Overview
 Table 70. Newchem S.p.A. Prostaglandin Analogs Product
 Table 71. Newchem S.p.A. Revenue in Prostaglandin Analogs Business (2020-2025) & (US$ Million)
 Table 72. Newchem S.p.A. Recent Development
 Table 73. Research Programs/Design for This Report
 Table 74. Key Data Information from Secondary Sources
 Table 75. Key Data Information from Primary Sources
 Table 76. Authors List of This Report


List of Figures
 Figure 1. Prostaglandin Analogs Picture
 Figure 2. Global Prostaglandin Analogs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prostaglandin Analogs Market Share by Type: 2024 VS 2031
 Figure 4. Xalatan Features
 Figure 5. Travatan Features
 Figure 6. Lumigan Features
 Figure 7. Tafluprost Features
 Figure 8. Global Prostaglandin Analogs Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Prostaglandin Analogs Market Share by Application: 2024 VS 2031
 Figure 10. Clinic Case Studies
 Figure 11. Hospital Case Studies
 Figure 12. Others Case Studies
 Figure 13. Prostaglandin Analogs Report Years Considered
 Figure 14. Global Prostaglandin Analogs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Prostaglandin Analogs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Prostaglandin Analogs Market Share by Region: 2024 VS 2031
 Figure 17. Global Prostaglandin Analogs Market Share by Players in 2024
 Figure 18. Global Top Prostaglandin Analogs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostaglandin Analogs as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Prostaglandin Analogs Revenue in 2024
 Figure 20. North America Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Prostaglandin Analogs Market Share by Country (2020-2031)
 Figure 22. United States Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Prostaglandin Analogs Market Share by Country (2020-2031)
 Figure 26. Germany Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Prostaglandin Analogs Market Share by Region (2020-2031)
 Figure 34. China Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Prostaglandin Analogs Market Share by Country (2020-2031)
 Figure 42. Mexico Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Prostaglandin Analogs Market Share by Country (2020-2031)
 Figure 46. Turkey Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Prostaglandin Analogs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Pfizer Revenue Growth Rate in Prostaglandin Analogs Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Prostaglandin Analogs Business (2020-2025)
 Figure 51. Merck Revenue Growth Rate in Prostaglandin Analogs Business (2020-2025)
 Figure 52. Allergan Revenue Growth Rate in Prostaglandin Analogs Business (2020-2025)
 Figure 53. Newchem S.p.A. Revenue Growth Rate in Prostaglandin Analogs Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS